• The Declining Value of Economics in Canadian Cancer Reimbursement Reviews

    Nov 1, 2016, 00:00

  • Comparison of Mirena Intrauterine Device with Oral Progesterone Treatment and Surgical Treatment in Idiopathic Menorrhagia Patients- Results of A Cost-Minimisation Analysis

    Nov 1, 2016, 00:00

  • A Systematic Review Of The Cost-Effectiveness Of Quadrivalent Influenza Vaccine

    Nov 1, 2016, 00:00

  • Societal Impact of One-Time Screening for Diabetes at Age 30 in the Indian Population- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Economic Evaluation of The Portuguese Needle Exchange Programme In Community Pharmacies (NEP-CP)

    Nov 1, 2016, 00:00

  • To What Extent Does the Published Economic Analyses of Treatments for Opioid Use Disorder Capture its Chronic, Relapsing Nature and its Impact on Society?

    Nov 1, 2016, 00:00

  • Clinical And Economic Outcomes Of Patients Hospitalized For Herpes Zoster In Hong Kong

    Nov 1, 2016, 00:00

  • Data Imputation for Missing Values in a Claim-Based Administrative Database- Comparison of Imputatation Approaches

    Nov 1, 2016, 00:00

  • The Coordination Of Care In Pmaq-Ab- An Analysis Based On The Item Response Theory

    Nov 1, 2016, 00:00

  • Understanding Continuity of Care at a Provider and Practice Level

    Nov 1, 2016, 00:00

  • Epidemiological Profiling of Chronic Headache Patients At A Public Tertiary Care Setting in India

    Nov 1, 2016, 00:00

  • Market Access In The Context Of Economic Crisis- Insights From Several European Countries

    Nov 1, 2016, 00:00

  • Health Insurance Treatment Cost of Colorectal Cancer in Hungary

    Nov 1, 2016, 00:00

  • Outcomes Prediction Using a Generalized Linear Model in a Cohort of Schizophrenic Patients Receiving Paliperidone Long Acting Injectable Treatment in Hong Kong

    Nov 1, 2016, 00:00

  • Psychometric Properties Of The Finnish Version Of The Locomotor Capabilities Index-5

    Nov 1, 2016, 00:00

  • The Impact of Different Gastrointestinal Symptoms on The Well-Being of Affected Patients - Utility Weights for The Gastrointestinal Symptom Score (GIS)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Rifaximin-Α Administration for the Reduction of the Overt Hepatic Encephalopathy Episodes in Recurrence in France

    Nov 1, 2016, 00:00

  • Burden of Cancers Attributable to Tobacco Smoking in Member Countries of the Association of South East Asian Nations (Asean), 2012

    Nov 1, 2016, 00:00

  • Study On Medication Adherence Behavior And Quality Of Life In Elderly Diabetc, Hypertension Patients In A Tertiary Care Hospital; A Prospective Study

    Nov 1, 2016, 00:00

  • Cost Analysis of Human Genome Sequencing in Cancer Diagnosis in Fran Next Generation Sequencing

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Sacubitril/Valsartan For The Treatment of Chronic Heart Failure with Reduced Ejection Fraction- The Use of Model Calibration To Improve Generalisability To A UK CHF Population

    Nov 1, 2016, 00:00

  • Pediatric Registry Of Patients With Severe Persistent Uncontrolled Asthma Receiving Omalizumab

    Nov 1, 2016, 00:00

  • Health Technology Assessment (HTA) for Orphan Drugs in Cost-Effectiveness (CE) Markets- Current Development and Future Trends

    Nov 1, 2016, 00:00

  • Developing a Geospatial Web and Mobile Application to Improve Expanded Program on Immunization in Ghana- A Mhealth Technology Novelty, 2015

    Nov 1, 2016, 00:00

  • The Emerging Roles of Pharmacists in Selected Tertiary Hospitals in Pangasinan and La Union- Focus on Pharmaceutical Care and Pharmacovigilance

    Nov 1, 2016, 00:00

  • Type 2 Diabetes in Turkey – A Cost of Illness Study

    Nov 1, 2016, 00:00

  • The Comparative Pharmacoeconomic Analysis of Using Different Reperfusion Strategies for Patients with St Segment Elevation Myocardial Infarction (STEMI)

    Nov 1, 2016, 00:00

  • Impact Of Post-Inscription Studies On Reassessment In Fran A Case Study On Orphan Drugs

    Nov 1, 2016, 00:00

  • Comparison of Medical Costs, Health Care Utilization, and Health Outcomes Between the Elderly with and Without Disabilities in Korea

    Nov 1, 2016, 00:00

  • Pharmacotherapies for the Treatment of Behavioral and Psychological Symptoms of Dementia - A Systematic Review On Recent Evidence

    Nov 1, 2016, 00:00

  • The Impacts of Case Payment in Rural Hainan of China

    Nov 1, 2016, 00:00

  • The Follow-Up and Utilization of Drug Treatment for Chronic Hbv/Hcv Patients with Major Psychiatric Diseases in Taiwan

    Nov 1, 2016, 00:00

  • The Effect of Traditional Medicine on Quality of Life in Patients with Atopic Dermatitis- A Review of Recent Clinical Trials

    Nov 1, 2016, 00:00

  • Applying A Simulation Model to Manage Waiting Lists For Hospital Inpatient Activity in AN EU Region

    Nov 1, 2016, 00:00

  • Risk of Motor-Vehicle Accidents Increases with Multimorbidity

    Nov 1, 2016, 00:00

  • Cost Of Total Parenteral Nutrition Services At Ministery Of Health In Saudi Arabia

    Nov 1, 2016, 00:00

  • Use of Real World Data in Identifying Relevant Comparators in Medico Economic Models at EU5 Level- A Case Study on Multiple Myeloma

    Nov 1, 2016, 00:00

  • Network Meta-Analysis Across Longitudinal Time Points- A Comparison of Available Methods

    Nov 1, 2016, 00:00

  • DRG Appropriateness Analysis Using Activity-Based-Costing Method – A Case of Burn Diagnosis

    Nov 1, 2016, 00:00

  • Assessment of Secondary Recurrence of Stroke in Aspirin-Clopidogrel Combination Therapy and Aspirin Monotherapy in Transient Ischemic Attack Patients in South India- A Comparative Study

    Nov 1, 2016, 00:00

  • Central Nervous System, Multiple Sclerosis And Social Security- The Economic Burden On The Social Security System Pensions In Italy

    Nov 1, 2016, 00:00

  • Oral And General Health Related Quality of Life In Times of Crisis In Greece

    Nov 1, 2016, 00:00

  • Real-World Quality-Adjusted Life-Years Gains In Portuguese Patients with Rheumatoid Arthritis Following 1 Year of Golimumab Treatment

    Nov 1, 2016, 00:00

  • Comparative Exploratory Analysis on Effectiveness, Tolerability And Patient/Nurse Satisfaction With Two Non-Invasive Patient Controlled Analgesia Treatments For Acute Post-Operative Pain Management

    Nov 1, 2016, 00:00

  • Observational Study on Daily Life Practice in 15039 Patient with Multiple Sclerosis in France

    Nov 1, 2016, 00:00

  • ORphan Drug Market Analysis In Turkey

    Nov 1, 2016, 00:00

  • Adoption of Innovative Technologies and Substitution Effects- Computed Tomographic Coronary Angiography In Australia

    Nov 1, 2016, 00:00

  • Choosing First-Line Treatment of Metastatic Colorectal Cancer Based on Biomarker Ras Status- A Budget Impact Analysis From Brazilian Health Insurance System Perspective

    Nov 1, 2016, 00:00

  • Self-Medication with Antibiotics in Sana'a City

    Nov 1, 2016, 00:00

  • The Economic Burden of Atrial Fibrillation in Latin America

    Nov 1, 2016, 00:00

  • Efficacy of The Fixed Combination of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Vs Traditional Topical Treatment In Psoriasis- A Bayesian Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Hospital Resource Utlization of Patients Over 40 Years old with Chronic Obstructive Pulmonary Disease in South Korea

    Nov 1, 2016, 00:00

  • Cost of Healthcare Among Metastatic Lung Cancer Patients Receiving Chemotherapy

    Nov 1, 2016, 00:00

  • Value Added Medicines- What Value Repurposed Medicines Might Bring To Society?

    Nov 1, 2016, 00:00

  • Health Outcomes Assessment and Treatment Regimens For Patients with Gastric Cancer in Shanghai China

    Nov 1, 2016, 00:00

  • Cost Study of Respiratory System Diseases

    Nov 1, 2016, 00:00

  • Cost-Utility of Denosumab For The Treatment of Postmenopausal Osteoporosis In Colombia

    Nov 1, 2016, 00:00

  • Effectiveness Of Self-Monitoring Of Blood Glucose (Smbg) In Reducing Hba1c Of Diabetes Mellitus Type-2 Patients In Jakarta, Indonesia- Preliminary Findings

    Nov 1, 2016, 00:00

  • Translation of the UK Paediatric Influenza Primary School Vaccination Programme to 13 European Countries Using a Dynamic Transmission Model

    Nov 1, 2016, 00:00

  • The Mosaic Study- Regional Variation in Treatment Patterns Associated with Progression from Initial Insulin Regimen

    Nov 1, 2016, 00:00

  • Health Care Applicability of A Patient-Centric Web Portal For Patients' Medication Experience

    Nov 1, 2016, 00:00

  • Burden of Medically Attended Acute Gastroenteritis in England- A Cohort Study in CPRD

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Serum Free Light Chain Assay (FREELITE®) for The Diagnosis of Monoclonal Gammopathy in The Brazilian Public and Private Healthcare Systems

    Nov 1, 2016, 00:00

  • Innovative Therapies for The Treatment of Cancer- An Overview of Late-Phase Clinical Development

    Nov 1, 2016, 00:00

  • Challenges in the Assessment of Medical Devices- Recommendations from the Medtechta Project

    Nov 1, 2016, 00:00

  • Real-World Treatment Patterns and Outcomes for Patients with Advanced Soft Tissue Sarcoma Receiving Systemic Therapy in The United Kingdom

    Nov 1, 2016, 00:00

  • Patient Group Submissions (PGSS) in Health Technology Assessment (HTA) In Scotland- Prevalence And Impact

    Nov 1, 2016, 00:00

  • The value of timely implementation in hiv/sti testing- cost-effectiveness vs. Speed of intervention rollout

    Nov 1, 2016, 00:00

  • Real Life Progression Free Survival and Treatment Patterns For Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapies in Fran Analysis of Ims Rwd Oncology Cross-Sectional Survey Data

    Nov 1, 2016, 00:00

  • Indicators in Evaluating Financial and Economic Performance of Pharmacy- A Systematic Review

    Nov 1, 2016, 00:00

  • Analysis of the Costs Associated with the Management of Adverse Events Compared Through Tkis in the Treatment of Patients with Non-Small Cells Lung Cancer EGFR Mutated

    Nov 1, 2016, 00:00

  • Impact of National Criteria and Healthcare System Characteristics on Access to Biologic Dmards in Rheumatoid Arthritis In Europe

    Nov 1, 2016, 00:00

  • The Burden of Selected Cancers in The United States- Health Behaviors and Healthcare Utilization of Survivors

    Nov 1, 2016, 00:00

  • The Importance of Model Conceptualisation- A Case Study in Ankylosing Spondylitis (AS) and Non-Radiographic Axial Spondyloarthritis (NR-AXSPA)

    Nov 1, 2016, 00:00

  • Systematic Review of Health State Utilities in Children with Asthma

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of the Pharmacist-Assisted Warfarin Monitoring Program (PAWM) at a Medical Center in Taiwan

    Nov 1, 2016, 00:00

  • Has Access To Innovative Therapies In Poland Improved Following The 2012 Reimbursement Act?

    Nov 1, 2016, 00:00

  • Comparing The Safety Profiles Of Biosimilars With Their Originators’- A Cross Sectional Analysis On The Eu-Rmp

    Nov 1, 2016, 00:00

  • The Dynamic Evolution of External Price Referencing Implementation in Various Countries

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life in Opioid use Disorder Measured by Utilities- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • The Good The Bad And The Non-Quantifiable – A Comparison of Rebates on Orphan Drugs Versus Non-Orphan Drugs In Germany

    Nov 1, 2016, 00:00

  • Real World Data in Health Technology Assessments –Use of Routinely Collected Data to Address Epidemiologic Questions in Kidney Transplantation in the Amnog Process in Germany

    Nov 1, 2016, 00:00

  • A Cost-Utility Analysis of Dabigatran, Enoxaparin, and Usual Care for Venous Thromboprophylaxis after Hip or Knee Replacement Surgery in Thailand

    Nov 1, 2016, 00:00

  • The Economic Burden of Schizophrenia in Malaysia

    Nov 1, 2016, 00:00

  • Invisible Lever for Access to Innovative Therapies in Bulgaria

    Nov 1, 2016, 00:00

  • Association of Patient-Reported Anxiety and Depression with Clinical Measurements, Disability, and Treatment Satisfaction Among Patients with Rheumatoid Arthritis

    Nov 1, 2016, 00:00

  • Effect of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Statins on Sepsis-Related Outcomes

    Nov 1, 2016, 00:00

  • Differentiation Of Health Related Quality Of Life Outcomes Between Patient Populations; Results From Patients With Breast Cancer, Rheumatoid Arthritis, Multiple Sclerosis, Rare Cancers And Rare Diseases

    Nov 1, 2016, 00:00

  • Global Evaluation of European Submission Template to Inform HTA and Payer Submissions

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam

    Nov 1, 2016, 00:00

  • Cost-Utility of Unicompartmental Compared To Total Knee Replacements- An Analysis Based on Matched Routinely-Collected Data From The United Kingdom

    Nov 1, 2016, 00:00

  • Factors Affecting Prolonged Length of Stay In Patents With Mood Disorders

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Oxaliplatin Plus Fluorouracil/Leucovorin (Folfox4) Compared to Sorafenib for Treatment of Advanced Hepatocellular Carcinoma Patients in China

    Nov 1, 2016, 00:00

  • Economic Evaluation Of Abbvie’s Regimen (Viekirax/Exviera) For Patients With Genotype 1a Hcv In Greece

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Everolimus for Patients with Advanced Neuroendocrine Tumors of the Gastrointestinal (GI) or Lung Origin -A Canadian Societal Health Care System Perspective

    Nov 1, 2016, 00:00

  • Systematic Literature Review and Assessment of the Reporting Quality of Economic Evaluation Studies in Non-Small Cell Lung Cancer in China

    Nov 1, 2016, 00:00

  • Cost Analysis of Levofloxacin 750mg During 5 Days Vs Levofloxacin 500mg During 10 Days for the Treatment of Comunity-Acquired Pneumonia Under the Brazilian Public Hospital Perspective

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Aspects of Different Inhibitors of Tyrosine Kinase in First-Line Therapy of Patients with Advanced Non-Small Cell Lung Cancer with A Mutation in Epidermal Growth Factor Receptor (EGFR) Gene

    Nov 1, 2016, 00:00

  • How Does Pricing and Access of Innovative Oncology Agents in China Compare with Other Asian Markets?

    Nov 1, 2016, 00:00

  • Barriers Influencing Implementation of Guidelines Into Clinical Practice in Czech Republic

    Nov 1, 2016, 00:00

  • Comparative Analysis of The Guidelines for Conducting Hta in Poland and Bulgaria

    Nov 1, 2016, 00:00

  • What is an Efficient and Affordable Trastuzumab Therapy in a Middle-Income Country? - Adjuvant Therapy with Trastuzumab in Management of Early HER2-Positive Breast Cancer in Iran

    Nov 1, 2016, 00:00

  • Weakness of Registration Bioequivalent Drugs

    Nov 1, 2016, 00:00

  • Impact of Adoption of A New Drug on the Trends in Utilization Patterns Changes and Pharmaceutical Expenditure- An Example of Urate-Lowering Therapy

    Nov 1, 2016, 00:00

  • Comparison of Healthcare Costs Between Rheumatoid Arthritis Patients Treated With Infliximab, Etanercept And Adalimumab In Nordic Setting

    Nov 1, 2016, 00:00

  • Identifying The Unmet Medical Need of Angelman Syndrome- Results of A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Drug Utilization Evaluation of Antibiotics in General Medicine Department of a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Diffusion of Trans-Arterial Radioembolization for The Treatment of Intermediate-Advanced Hepatocellular Carcinoma in Italy- A Budget Impact Analysis

    Nov 1, 2016, 00:00

  • How Gifts and Brand Reminders Influence the Generic Brand Selection Among Physicians?

    Nov 1, 2016, 00:00

  • Review of Clinical Practice Guidelines and Treatment Patterns in Metastatic Pancreatic Cancer in EU-5 Countries

    Nov 1, 2016, 00:00

  • A Systematic Review- Economic Burden Of Needlestick Injuries On Healthcare Workers

    Nov 1, 2016, 00:00

  • The Pareto Principle ("80−20 Rule") In Healthcare Services In Greece

    Nov 1, 2016, 00:00

  • Impact of Inadequate Insulin Resuspension (IIR) on Clinical, Patient And Economic Outcomes- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Economic Burden of Gefitinib Versus Pemetrexed for Insured Patients with Lung Cancer in Urban Xinjiang Province, China- A Real World Research

    Nov 1, 2016, 00:00

  • Benefits of An Automatic Tool For Glucose Pattern Detection

    Nov 1, 2016, 00:00

  • The Cost Of Multiple Sclerosis In 16 European Countries- Functional Status, Symptoms And Mental Factors Drive Costs

    Nov 1, 2016, 00:00

  • Chemotherapy, Cytokines and Cancer-Related Fatigue- A Systematic Review of Quantitative Studies in 1312 Patients

    Nov 1, 2016, 00:00

  • Treatment of Upper-Extremity Sarcoma with Limb-Salvage Procedures Showed Good Functional Outcomes- A Pilot Study Of 13 Consecutive Patients

    Nov 1, 2016, 00:00

  • Comparing Coronary Artery Disease Treatment Outcomes – An Example Based on Health-Related Quality of Life Measurements

    Nov 1, 2016, 00:00

  • The Impact of Atrial Fibrillation on the Economic Burden of Ischemic Stroke Patients in Beijing

    Nov 1, 2016, 00:00

  • Association Between Stages of Change and Medication Adherence Among Diabetic Patients in a Primary Health Care Setting in Qatar- A Preliminary Study

    Nov 1, 2016, 00:00

  • Use of Health Economic Information in the Management of Health Care Resource Allocation

    Nov 1, 2016, 00:00

  • Combination Oncologics- A Boon or Burden to Healthcare Systems?

    Nov 1, 2016, 00:00

  • A Simulation Model for Peripheral Arterial Disease- Methods and Application of A Markov Model

    Nov 1, 2016, 00:00

  • A Prospective Analysis of Adverse Drug Reaction in A Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Analysis of Two Pressure Ulcer Dressings for Cost Reduction In The Brazilian Public Health System

    Nov 1, 2016, 00:00

  • The Value Of Patient Reported Outcomes In German Amnog Dossiers

    Nov 1, 2016, 00:00

  • The Utilization Of Selected Screening Tests In Gree A Descriptive Analysis

    Nov 1, 2016, 00:00

  • Costs of Perennial Allergic Rhinitis And Asthma Increase with Level of Severity And Level of Disease Control

    Nov 1, 2016, 00:00

  • Artificial Integligence To Support The Development Of Health Technology Assessment Reports

    Nov 1, 2016, 00:00

  • Financial Analysis of the Final Prices, Co-Paymants and Reimbursment of Antihypertensives in Slovakia from 2008-2014

    Nov 1, 2016, 00:00

  • A Qualitative Comparison of German and UK Health Technology Assessments- Vedolizumab Case Study

    Nov 1, 2016, 00:00

  • Review of Multicriteria Decision Analysis Application for Decision-Making in Oncology

    Nov 1, 2016, 00:00

  • Local Utilities for Local Studies- Data Availability and Methodology in Japan and Korea

    Nov 1, 2016, 00:00

  • The Study of the Effect of Pharmacy Manager's Managerial Skills on the Performance of Community Pharmacies of Tehran

    Nov 1, 2016, 00:00

  • Pricing and Market Access of Orphan Drugs in China- Analysis of National and Provincial Policy and the Associated Impact on Coverage

    Nov 1, 2016, 00:00

  • Spill Over Economic Impacts on Families of Children Receiving Hospital-Based Care

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis of Alternative Treatment Options for Colorectal Cancer in Greece

    Nov 1, 2016, 00:00

  • A Review on the Current Status of Health Economic Modeling in Personalized Medicine

    Nov 1, 2016, 00:00

  • Treatment Patterns, Biomarker Testing (BMX) Practices and Healthcare Resource Use (HCRU) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) in Taiwan

    Nov 1, 2016, 00:00

  • Kidney-Related Complications Are Associated With Worse Outcomes Among Hospitalized Children With Autosomal Dominant Polycystic Kidney Disease In The US

    Nov 1, 2016, 00:00

  • Changing Of Prescriptions For Diabetes, Hyperlipidemia, And Hypertension, From Generic Drugs To Protected Brand Drugs - A Retrospective Cohort Study Using A National Inpatient Database In Japan

    Nov 1, 2016, 00:00

  • Analysis Of Real Data For Treatment Of Nausea And Vomiting Of Pregnancy (Nvp) In Ukraine

    Nov 1, 2016, 00:00

  • Health Insurance Cost of Stroke in Hungary- A Cost of Illness Study

    Nov 1, 2016, 00:00

  • Understanding Health Technology Assessment (HTA) Bodies in Major Latin-American (LATAM) Markets- Systematic Evaluation in 5 Latam Countries

    Nov 1, 2016, 00:00

  • Evaluation of the Direct Costs of Health Care During the First Year of Life of Babies Born with Microcephaly in the SUS

    Nov 1, 2016, 00:00

  • Widening Engagement with HTA Though open online Learning

    Nov 1, 2016, 00:00

  • A Cost-effectiveness Analysis of Pharmacokinetic (Pk) Driven Prophylaxis VS. Standard Prophylaxis In Haemophilia A

    Nov 1, 2016, 00:00

  • Estimating the Economic Impact Due to Productivity Losses of Diabetes and Major Depressive Disorder in Singapore- Human Capital Versus Friction cost Approaches

    Nov 1, 2016, 00:00

  • A Secure Smartphone Application For Clinical Research On Wound Healing- Nurstrial

    Nov 1, 2016, 00:00

  • Disease Modifying Treatment (Dmt) is Associated with Lower Hazard for Death Among Multiple Sclerosis (Ms) Patients- Survival Analysis Based on 30 Years Incident Ms Cohort

    Nov 1, 2016, 00:00

  • Adverse Events in Relaxing Virtual Environments

    Nov 1, 2016, 00:00

  • Substitutability of Dry Powder Inhalers- A Perspective from German Pulmonologists

    Nov 1, 2016, 00:00

  • Study on Age-Related Drug Use Pattern and Assessment of Medication Adherence in Patients with Chronic Respiratory Diseases

    Nov 1, 2016, 00:00

  • Perception Survey on Health Technology Assessment in Turkey- Does Practice Meet with Regulations

    Nov 1, 2016, 00:00

  • Don't Put Off Until Tomorrow What You Can Do Today- Cost-Effectiveness of Trastuzumab Plus Paclitaxel Combination Therapy and Sequential use of Paclitaxel and Trastuzumab in the Treatment of Metastatic Breast Cancer in Singapore

    Nov 1, 2016, 00:00

  • The Effectiveness of Pre-Filled Versus Manually Filled Flush Syringes in Intravascular Devices Maintenan A Meta-Analysis

    Nov 1, 2016, 00:00

  • Correctly Capturing Uncertainty in Treatment Effects in Simulation Modeling

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Obinutuzumab And Ibrutinib In Patients With Chronic Lymphocytic Leukemia In Russia

    Nov 1, 2016, 00:00

  • COPD Drugs In Europe - A Comparison of Market Access Decisions In France, Germany, Sweden and UK with The Prismaccess Database

    Nov 1, 2016, 00:00

  • National Survey of Drug Information Centers Practice in Saudi Arabia- Evidence Based Medicine-Therapeutics Guidelines System (Ebm-Tg) At Moh

    Nov 1, 2016, 00:00

  • The Evolution Of Patient Access Schemes

    Nov 1, 2016, 00:00

  • The Effect of Necitumumab in Combination with Gemcitabine-Cisplatin on Health-Related Quality of Life (HRQOL) and Tolerability- Squire Trial Patients with Epidermal Growth Factor Receptor (EGFR)-Expressing Squamous NSCLC Tumours

    Nov 1, 2016, 00:00

  • Social Return on Investment in Psoriasis

    Nov 1, 2016, 00:00

  • Patient Compliance to Treatment with Gliclazide for Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Systematic Review Of Studies Estimating The Cost-Effectiveness Of Hiv Pre-Exposure Prophylaxis (Prep) In Men Who Have Sex With Men (Msm)

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life in Patients with Rheumatoid Arthritis At Uttaradit Hospital, Thailand

    Nov 1, 2016, 00:00

  • HTA On Role of Chitosan In Hemostasis

    Nov 1, 2016, 00:00

  • Economic Burden of Varicella In Children In Poland, 2011–2015

    Nov 1, 2016, 00:00

  • Budget Impact of Secukinumab For Ankylosing Spondylitis In The UK

    Nov 1, 2016, 00:00

  • Health Care Utilization and Economic Burden of Pancreatic Cancer in The Us Medicare Population

    Nov 1, 2016, 00:00

  • The Shift From A Compassionate Drug Use To The Common Market–Access Process- An Inflationary No Man’s Land?

    Nov 1, 2016, 00:00

  • Access To New Drugs After The Introduction Of The 2011 Reimbursement Act In Poland

    Nov 1, 2016, 00:00

  • Rapid Health Technology Assessment – Valveless Trocar System for Advanced Laparoscopic / Robotic Surgery

    Nov 1, 2016, 00:00

  • Mapping Transactions from Pharmaceutical Companies to Healthcare Organisations in the EU5

    Nov 1, 2016, 00:00

  • Institute for Clinical and Economic Review (ICER) VS. Health Technology Assessment (HTA) Agencies- The Case of Multiple Myeloma and PCSK9S

    Nov 1, 2016, 00:00

  • Economic Burden Of Primary Immunodeficiency In National Institute Of Pediatrics In Mexico

    Nov 1, 2016, 00:00

  • Pivotal Studies of Oncology Drugs Approved in Europe, Which Evidence Based-Medicine?

    Nov 1, 2016, 00:00

  • The Patient Journey After A Diagnosis of Early/Locally Advanced Breast CA In Greece And Choice of Provider

    Nov 1, 2016, 00:00

  • Price And Utilization Of New Drugs Under A Single Public Payer System- Evidence From Taiwan

    Nov 1, 2016, 00:00

  • Deterministic Vs Microsimulation; A Case Study In Systemic Lupus Erythematosus (SLE)

    Nov 1, 2016, 00:00

  • To Evaluate the Outcomes of Concomitant Chemoradiotherapy Followed by Extended Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma - A Retrospective Study

    Nov 1, 2016, 00:00

  • The use of Alhijama as Complimentary Treatment in Hypertension

    Nov 1, 2016, 00:00

  • Self-Reported Sleep Quality, Duration And Health-Related Quality Of Life In Older Chinese

    Nov 1, 2016, 00:00

  • Comparative Analysis of Consumption of Antipsychotic Drugs For Treating Schizophrenia in Hospitals in Russian Federation

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Analysis of Pegylated Liposomal Doxorubicin Versus Doxorubicin In Patients with Metastatic Breast Cancer at High Risk of Cardiac Events

    Nov 1, 2016, 00:00

  • Cost Comparison Of Medical And Surgical Treatments For Medically Intractable Epilepsy

    Nov 1, 2016, 00:00

  • Cost-Effectivness Analysis of Axitinib In The Treatment of Metastatic Renal Cell Carcinoma – Clinical Data Vs RWE

    Nov 1, 2016, 00:00

  • Increase Hospital Physicians’ Awareness of Expenditure Generated by Their Prescription in the Ambulatory Sector- Learning from the Experience of the 37 Public Hospitals of Paris in Diabetology

    Nov 1, 2016, 00:00

  • Evaluation of the Number Needed to Vaccinate (NNV) with Gardasil9 in order to Avert 1 Case of Human Papillomavirus (HPV)-Related Anogenital Disease in France

    Nov 1, 2016, 00:00

  • Influence of Medical–Economic Analysis on the Categorization of Special Medical Equipment

    Nov 1, 2016, 00:00

  • Bevacizumab in The Treatment of Kras Wild Type Metastatic Colorectal Cancer- An Economic Analysis Based on The Calgb 80405 Trial

    Nov 1, 2016, 00:00

  • Diversity in Economic Evaluations Hampers Valid Decision-Making in Metastatic Colorectal Cancer

    Nov 1, 2016, 00:00

  • Thresholds for Clinical Importance in EORTC-QLQ-C30- Application in A Sample of Colorectal Cancer Patients

    Nov 1, 2016, 00:00

  • Incidence Cancer Costs Associated with Head And Neck (HN) Cancers- A Nationwide Study From France In 2008-2013 (EPICORL STUDY)

    Nov 1, 2016, 00:00

  • Review of the Recommendations Made by the National Institute for Health and Care Excellence (NICE) and the Scottish Medicial Consortium (SMC) Relating to Treatments for Rare Diseases

    Nov 1, 2016, 00:00

  • The Effects Of Food Prices On Weight Outcomes. A Systematic Review Of The Moderating Effects Of Income And Initial BMI

    Nov 1, 2016, 00:00

  • Market Access Challenges of Drugs for Chronic Hepatitis C- A Thematic Analysis of Health Technology Assessments

    Nov 1, 2016, 00:00

  • Management of Patients with Statin Intoleran Results from a Survey of Clinicians in Six European Countries

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Tocilizumab Subcutaneouscombotherapy First Line For The Management of Rheumatoid Arthritis In Greece

    Nov 1, 2016, 00:00

  • The Effects of Pay for Response and Maximum Price CAP Schemes on Payer and Provider Risk

    Nov 1, 2016, 00:00

  • The Impact of Haemophilia Complications on Health-Related Quality of Life for Adults with Severe Haemophilia

    Nov 1, 2016, 00:00

  • Assessment Of Prices Of Essential Medicines For Chronic Diseases Prevalent In The Asia Pacific Region

    Nov 1, 2016, 00:00

  • Ethical and Technological Evaluation of Security of Connected Objects and Health Applications- How to Move Towards Certification

    Nov 1, 2016, 00:00

  • Prescription Data in Australia- How Useful is this ‘Big' Data?

    Nov 1, 2016, 00:00

  • The Trends of Emergency Care Admissions Focusing on The Population Over 65 Years of Age

    Nov 1, 2016, 00:00

  • Automatic Extraction and Classification of Patients’ Smoking Status from Free Text Using Natural Language Processing

    Nov 1, 2016, 00:00

  • A Case Study on the Development, Implementation and Outcome of Critical Disease Insurance in Shen Zhen, China

    Nov 1, 2016, 00:00

  • Prevalence of Severe Asthma and Poorly Controlled Severe Asthma During 2009–2013 in The Netherlands

    Nov 1, 2016, 00:00

  • Adaptive Prediction of Symptoms Return Upon Discontinuation of Omalizumab Treatment in Chronic Spontaneous Urticaria Patients

    Nov 1, 2016, 00:00

  • Market Regulation May Influence Drug Price Trajectories - A Comparison of Anti Tumor Necrosis Factor Drug Prices In Israel And The USA

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Introducing Pharmacist-Managed Warfarin Service In The Republic of Serbia

    Nov 1, 2016, 00:00

  • A Meta Regression Analysis of Utility Weights for Breast Cancer

    Nov 1, 2016, 00:00

  • The Prevalence Of Sexual Dysfunctions Among Hungarian Men

    Nov 1, 2016, 00:00

  • Economic Evaluation of Everolimus as Second-Line Treatment of Metastatic Renal Cell Carcinoma in Greece

    Nov 1, 2016, 00:00

  • Clinical Outcome and Health Care Costs of Blood Stream Infections with Resistant Klebsiella Pneumoniae in Pediatric Patients

    Nov 1, 2016, 00:00

  • Retrospective Review of Observational Data Requested by the French Health and Technology Assessment Agency- How are Results Taken Into Account?

    Nov 1, 2016, 00:00

  • Switching Patterns from Warfarin to Non-Vitamin K Oral Anticoagulants In Ireland

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Insulin Degludec/Insulin Aspart (IDEGASP) Compared with Biphasic Insulin Aspart (BIASP 30) in Patients with Type 2 Diabetes Mellitus from a Mexican Healthcare Perspective

    Nov 1, 2016, 00:00

  • Comparison of Economic Evaluation Guidelines Between Japan and other Countries

    Nov 1, 2016, 00:00

  • Burden of Visual Impairment Due to Myopic Choroidal Neovascularisation (MCNV) in Turkey

    Nov 1, 2016, 00:00

  • The Medication Adherence in Schizophrenia Management by Using Second Generation Antipsychotics in Taiwan- A Population Study Based on Nhrid

    Nov 1, 2016, 00:00

  • Literature Review of Studies Evaluating Cost Effectiveness of Prostaglandins and ß-Blockers in Primary Open Angle Glaucoma Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Levofloxacin Inhalation Solution Vs. Aztreonam Inhalation Solution And Tobramycin Dry Powder For Inhalation In Cystic Fibrosis Patients In Sweden

    Nov 1, 2016, 00:00

  • A Prospective Assessment of Attitudes and Experiences Among Urologists Regarding off Label Use of BCG Vaccine in Serbia

    Nov 1, 2016, 00:00

  • Health Insurance-Related Aspects Of Home-Based Parenteral Nutrition In Hungary

    Nov 1, 2016, 00:00

  • When Cost Saving Technologies are Not Adopted Despite Evidence and Payer Recommendations – Intraoperative Fluid Management (IOFM) in the UK

    Nov 1, 2016, 00:00

  • Non-Parametric Approach to Estimating Expected Value of Perfect Information- The Usefulness of this Approach to a National HTA Agency

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Colorectal Cancer Screening in Austria and Assessment of The Impact of Cancer-Causing Risk Factors

    Nov 1, 2016, 00:00

  • Prevalence and Management of Anemia in Patients of Chronic Kidney Disease at a Tertiary Care Public Teaching Hospital- Evidence from a Cross Sectional Study

    Nov 1, 2016, 00:00

  • A Quantitative Analysis of Health Technology Assessment (HTA) Agencies for Attributes Driving Transparency of the Organization- Comparison of Six Asia-Pacific HTA Agencies

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Rituximab in the Treatment of Diffuse Large B-Cell Non-Hodgkin's Lyphoma Patients (Dlbcl) in China

    Nov 1, 2016, 00:00

  • Cost-Benefit Analysis for Direct Visual Observation of Nasogastric Enteral Feeding Tube Placement

    Nov 1, 2016, 00:00

  • Zinforo (Ceftaroline Fosamil) Versus other Empiric Initial IV Antibiotics for Complicated Skin and Soft Tissue Infections (CSSTI)- A Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Assessment Of Knowledge And Practice Regarding Foot Care Of Diabetes Mellitus Patient In Tertiary Care Hospitals, Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Matching Adjusted Indirect Comparison (MAIC) Analysis For Ponatinib Vs Bosutinib In Third-Line Chronic Phase Chronic Myeloid Leukemia (CP-CML)

    Nov 1, 2016, 00:00

  • Evaluating Socio-Demographic Characteristics Of Patients In The United States Department Of Defense Population

    Nov 1, 2016, 00:00

  • Cardiovascular Diseases- Pharmacotherapy Utilization In Western Europe and CEE

    Nov 1, 2016, 00:00

  • Economic Burden of Stroke- A Systematic Review on Post-Stroke Care

    Nov 1, 2016, 00:00

  • Antiviral Activity and Embryonic Toxicity of Moxidectin Against Influenza Virus H9

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Insulin Degludec Treatment in Patients with Type1 and Type 2 Diabetes Mellitus- A Systematic Review

    Nov 1, 2016, 00:00

  • Comprehensive Evaluation of Health Care Workers Perceptions and Attitude on Pharmacists Involvement in Ward Round in Three Tertiary Hospitals in South-East Nigeria

    Nov 1, 2016, 00:00

  • Treatment Cost Estimation of Chronic Gastritis Caused by Helicobacter Pylori

    Nov 1, 2016, 00:00

  • Reform of Chinese State-Owned Enterprise-Affiliated Hospital

    Nov 1, 2016, 00:00

  • Guidelines for Translation and Cross-Cultural Adaptation of Non-Technical Skills Rating Instruments

    Nov 1, 2016, 00:00

  • Comparing Preferences Of Patients With Rheumatic Diseases, Of Experienced Rheumatologists, Nurses And Pharmacists Toward The Treatment Of Rheumatic Diseases With Biological Agents- Results From The Cara Study

    Nov 1, 2016, 00:00

  • Real World Data on the Adherance to the National Policy of Integrative and Complementary Practices in the Brazilian Unified Health System - The Acupuncture Case

    Nov 1, 2016, 00:00

  • Is the Integrated Electronic Health Record Cost-Effective for a Cancer Consultation? Results from the E-SI (PREPS-SIPS) Study

    Nov 1, 2016, 00:00

  • The Choice of A Fluoropyrimidine Regimen in Patients with Advanced Colorectal Cancer

    Nov 1, 2016, 00:00

  • DPP-4 Inhibitors and Cardiovascular Events in Type 2 Diabetic Patients with Chronic Kidney Disease -- A Nationwide Cohort Study

    Nov 1, 2016, 00:00

  • Quantification Of Quality Of Life Differences Due To Common Diseases In The Age Group 50+ In The United Kingdom

    Nov 1, 2016, 00:00

  • Bilirubin and Neurodegenerative Disease Prevention

    Nov 1, 2016, 00:00

  • Construction of System Dynamics Model for Medical Care System of Japan

    Nov 1, 2016, 00:00

  • Important Methodological Considerations and Strategies for Resolution for Multinational Retrospective Chart Review Studies

    Nov 1, 2016, 00:00

  • A Cost of Illness Study Evaluating The Burden of Wolfram Syndrome In The United Kingdom

    Nov 1, 2016, 00:00

  • Real World Anaplastic Lymphoma Kinase (ALK) Rearrangement Testing Patterns, Treatment Sequences and Survival of ALK-Inhibitor Treated Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Recombinant Human Follicle Stimulating Hormone Biosimilars In Portugal

    Nov 1, 2016, 00:00

  • Effective Use of Short-Term Healthcare By Immigrants In Chile- Linking Evidence To Policy For Universal Coverage

    Nov 1, 2016, 00:00

  • Parametric and Non-Parametric Approaches for Predicting Bacterial Resistance

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Pasireotide Long-Acting Compared To Continued Use of A First-Line Somatostatin Antagonist For The Treatment of Acromegaly In Sweden

    Nov 1, 2016, 00:00

  • Patient Information And Consent Form In Europe- Requirements From Regulatory Authorities For Pharmaco-Epidemiological Studies

    Nov 1, 2016, 00:00

  • Tasks Involved In Platelet Production And Transfusion From The U.S. Hospital Perspective- Two Process Frameworks

    Nov 1, 2016, 00:00

  • Management of Children's Acute Diarrhea by Community Pharmacies in Five Towns of Ethiopia- Simulated Client Case

    Nov 1, 2016, 00:00

  • Treatment of Osteochondral Fracture and Medial Patellofemoral Ligament Rupture After Patellar Dislocation

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Sucroferric Oxyhydroxide in Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease

    Nov 1, 2016, 00:00

  • Cost Per Responder of Lixisenatide Versus Rapid-Acting Insulin Intensification Regimens in an Insulin-Exposed Type 2 Diabetes Mellitus (T2DM) Population

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Nivolumab Monotherapy for Metastatic Melanoma Treatment

    Nov 1, 2016, 00:00

  • Investigating Influenza Vaccinations for Risk Groups in Ukraine

    Nov 1, 2016, 00:00

  • The Economic Burden of Heart Failure in Latin America

    Nov 1, 2016, 00:00

  • Cost Patterns in Patients Treated with Spinal Cord Stimulation Following Spine Surgery—A Register Based Study

    Nov 1, 2016, 00:00

  • High Levels Of Fears Of Patients With Rheumatoid Arthritis Or Axial Spondyloarthritis Are Associated With Gender, Disease Activity, Anxiety And Depression- A Cross-Sectional Study Of 672 Patients

    Nov 1, 2016, 00:00

  • Retrospective Database Study Describing Patient Characteristics And Resource Use in Swedish Patients Receiving Second Generation Long Acting Injection Antipsychotics

    Nov 1, 2016, 00:00

  • How Does the Additional Benefit Extend of Orphan Drugs Impact Price Negotiations in the German Outpatient Sector?

    Nov 1, 2016, 00:00

  • Economic Evaluation of Drug Therapy To Prevent Osteoporotic Fractures In Postmenopausal Women With Osteopenia

    Nov 1, 2016, 00:00

  • Safety Profile of Daclizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2016, 00:00

  • The Evolution of Risk-Sharing Agreements in the Process of Updating the National List of Health Services in Israel

    Nov 1, 2016, 00:00

  • Iatrogenic Hypoglycaemia in the Elderly- An Analysis of Diabetic Medication Usage Patterns According to Age

    Nov 1, 2016, 00:00

  • 19th Euro - FDS Financial Disclosure Statements

    Nov 1, 2016, 00:00

  • Health Economics Analyses for Medical Devices in Asia- A Literature Review

    Nov 1, 2016, 00:00

  • Evaluation of Health Care Costs and Utilization Patterns for Patients with Gout in Taiwan

    Nov 1, 2016, 00:00

  • Severe Sepsis In Adults- Impact of Diagnostic Coding on Hospital Resource Utilization

    Nov 1, 2016, 00:00

  • Missing the Value of Herd Immunity in Cost-Effectiveness Analysis. A Systematic Review

    Nov 1, 2016, 00:00

  • A Cost-Utility Analysis of the Risk Model-Guided Antiemetic Prophylaxis Versus Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer- A Net-Benefit Regression Approach

    Nov 1, 2016, 00:00

  • Clinical Responses and Improvements in Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol

    Nov 1, 2016, 00:00

  • Increased Use of Effective Non-Cancer Drugs Following Removal of Benefit Caps Among Cancer Patients In Medicaid- A Quasi-Experimental Study

    Nov 1, 2016, 00:00

  • Analysis of Antibiotics’ Use in the Treatment of Tonsillopharyngitis in Children Population of Nis District

    Nov 1, 2016, 00:00

  • A Systematic Review Comparing Studies of Cardiovascular Event Utilities by Geographic Region

    Nov 1, 2016, 00:00

  • GLP-1 Receptor Agonist Treatment-Related Features Important to Type 2 Diabetes Mellitus (T2DM) Patients- A Preference Study in Germany

    Nov 1, 2016, 00:00

  • ‘Severe Illness Insurance' in China- Impact of the New Coverage on Access to Health Care and Innovative Drugs

    Nov 1, 2016, 00:00

  • The Longterm Cost Effectiveness of the “Coaching Patients on Achieving Cardiovascular Health” (Coach) Program in Type 2 Diabetes in Tasmania

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of National Screening Program for Pulmonary Tuberculosis in Korea

    Nov 1, 2016, 00:00

  • Exploring The Potential Value of Improved Care for Secondary Hyperparathyroidism (SHPT) with A Novel Investigational Calcimimetic Therapy

    Nov 1, 2016, 00:00

  • Economic Evaluation of Diacerein, Diclofenac and Glucosamine for Osteoarthritis in China

    Nov 1, 2016, 00:00

  • Number Needed to Treat and Cost Per Clinically Meaningful Outcome of Enzalutamide and Abiraterone Acetate for The Treatment of Metastatic Castration-Resistant Prostate Cancer That Failed Androgen Deprivation Therapy in Brazil

    Nov 1, 2016, 00:00

  • Dose Increase Beyond Labelled Dose of Biologic Treatments in Moderate to Severe Psoriasis is Associated with Incremental Pharmacy Costs- A Real-World Study in the UK

    Nov 1, 2016, 00:00

  • Variations in Stakeholder Preferences between Innovative Pricing Agreement Types Across the EU5

    Nov 1, 2016, 00:00

  • How is Radiotherapy Reimbursed Across Europe? Results of The Health Economics in Radiation Oncology’s Survey

    Nov 1, 2016, 00:00

  • Decision Uncertainty and Need for Further Research- A Case-Study in Fenestrated Endovascular Aneurysm Repair for Complex Abdominal Aortic Aneurysms

    Nov 1, 2016, 00:00

  • Effect Of A Multifactorial, Interdisciplinary Intervention On Falls And Fall Rate Of The Older People In The Community

    Nov 1, 2016, 00:00

  • TBO-Filgrastim Patterns of Care by Treatment Site and Setting in The United States, 2014 and 2015

    Nov 1, 2016, 00:00

  • Health Technology Assessment of the use Vaccines for Prevention Flu

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Of Two Type-A Botulinum Toxins In The Management Of Blepharospasm And Cervical Dystonia In Spain

    Nov 1, 2016, 00:00

  • Drug Use Analysis of Patients with Hypertension and Diabetes in Shanghai, China- Based on Drug Bidding Database of Shanghai Medical Instituions

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of D-Dimer in The Diagnosis of Venous Thromboembolism in Colombia

    Nov 1, 2016, 00:00

  • A Time Series Analysis of Social Insurance and Patient Costs of Reimbursed Medical AIDS in Hungary

    Nov 1, 2016, 00:00

  • Assessment of Adhesion Response To 3D Printed Materials For Ophthalmic Device Development

    Nov 1, 2016, 00:00

  • Increasing the Interpretability of Patient-Reported Outcomes Questionnaire Findings Using A Mixed Methods Design- An Example in A Rare Cardiac Clinical Trial

    Nov 1, 2016, 00:00

  • Burden of Low Vision and Blindness in Chinese Elder Popullation-Data from Field Survey

    Nov 1, 2016, 00:00

  • Impact of The International Reference Pricing on Access To Standard Therapy Drugs for Asthma and Copd

    Nov 1, 2016, 00:00

  • How much do the insured citizens know about the personal account of china's urban employees' basic medical insurance and what are their needs? Evidence from guizhou, china

    Nov 1, 2016, 00:00

  • An Indirect Comparison Between Adalimumab, Baricitinib And Tofacitinib For The Treatment of Rheumatoid Arthritis

    Nov 1, 2016, 00:00

  • Course of Therapy, Resource Utilization and Costs for The Treatment of Metastatic Colorectal Cancer in Germany

    Nov 1, 2016, 00:00

  • HBSAG Seroclearance after Treatment-Induced HBEAG Seroclearance in Chronic Hepatitis B Patients in Beijing, China

    Nov 1, 2016, 00:00

  • Health State Utility Values (Hsuvs) Measured By The Euroqol 5-Dimensions (Eq-5d) Questionnaire In People Living With Hiv (Plhiv)- A Systematic Literature Review (Slr) Using Rapid Review Methodology

    Nov 1, 2016, 00:00

  • The Prescribing, Inpatient, Outpatient and Social Care Costs Associated with Atrial Fibrillation in Scotland- A Record Linkage Study

    Nov 1, 2016, 00:00

  • Systematic Review of Eq-5d Based Utility Scores in Leukemias

    Nov 1, 2016, 00:00

  • Health State Utilities for Persistent, Recurrent or Metastatic Cervical Cancer in France

    Nov 1, 2016, 00:00

  • The Burden of Severe Asthma in France

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilisation Associated with Patients Treated with Either Exenatide Once Weekly or Basal Insulin- A Retrospective UK Database Analysis

    Nov 1, 2016, 00:00

  • Understanding Health Technology Assessment (HTA) Bodies in Major Asia-Pacific (APAC) Markets- Systematic Evaluation in 10 APAC Countries

    Nov 1, 2016, 00:00

  • Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices in Germany

    Nov 1, 2016, 00:00

  • Cost of Illness Study In Patients With Myasthenia Gravis Treated With Plasma Exchange Therapy In Belgium

    Nov 1, 2016, 00:00

  • Stroke Treatment Cost Analysis for Consideration on Health Cost Determination Using INA-CBG'S (Indonesia Case Based Groups) in Indonesia National Health Insurance Programme 2014

    Nov 1, 2016, 00:00

  • Current Issues and Future Research Priorities for Health Economic Modelling of at Risk Population for Alzheimer’s Disease/Dementia

    Nov 1, 2016, 00:00

  • Budget Impact Of Ulipristal Acetate 5mg In Pre-Operative Treatment Of Uterine Fibroids- An Analysis Based On Public Data On Hospital Stays In France

    Nov 1, 2016, 00:00

  • Measuring Of The Uncertainty In Reimbursement System For Medicinal Products

    Nov 1, 2016, 00:00

  • Cost Minimization Of Using Activated Prothrombin Complex Concentrate Versus Recombinant Activated Factor Vii In Patients With A Nd B Hemophilia In Presence Of Inhibitors

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Brivaracetam Versus Other Antiepileptic Drugs Used as Adjunctive Treatment for Focal Seizures in the Uk- A Discrete Event Simulation Model

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Sequential USE of ELF/ARFI Test Versus Biopsy to Assess Liver Fibrosis in Chronic HCV

    Nov 1, 2016, 00:00

  • Trend in HBA1C Levels Among Primary Care Diabetes Patients Admitted to a Tertiary Hospital in Singapore in 2013

    Nov 1, 2016, 00:00

  • Patient Access to High-Cost and High-Value Specialty Products in China- Review of Decisions From Zhejiang, Neimenggu, Shandong and Jiangxi

    Nov 1, 2016, 00:00

  • Impact of Potential Drug Interactions in Cardiac Patients on Morbidity Risk- An Observational Prospective Approach

    Nov 1, 2016, 00:00

  • Self-Efficacy And Health Behaviors Impact Quality Of Life Of Elderly Along Eastern Sea Coast Of Thailand 2015

    Nov 1, 2016, 00:00

  • Health Related Quality of Life In The Deaf British Signing Population

    Nov 1, 2016, 00:00

  • Evaluating The Experiential Quality of Older People's Community Care- A Concept Mapping Approach To Instrument Design

    Nov 1, 2016, 00:00

  • Patients' Educational Background was Associated with the Validity and Reliability of a Health-Related Quality of Life Questionnaire

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Evaluation of Acarizax® In Patients with House Dust Mites Induced Allergic Asthma And Allergic Rhinitis In Slovakia

    Nov 1, 2016, 00:00

  • Trans-Pacific Partnership Agreement And Its Impact On Accessibility And Affordability Of Medicines- A Meta-Synthesis

    Nov 1, 2016, 00:00

  • Cost Variations of Inpatient, Daycare and Outpatient Hysteroscopy in A Tertiary-Care Hospital in Malaysia

    Nov 1, 2016, 00:00

  • Economic Benefits of Cpap Treatment for Obstructive Sleep Apnea in The Elderly

    Nov 1, 2016, 00:00

  • Soft Modelling Of Health-Related Quality Of Life Specific To Hiv In Relation To Anxiety, Depression, Personality Traits And Precariousness

    Nov 1, 2016, 00:00

  • The Road to Russian Pharmacoeconomics- Understanding the Drivers for Access to High-Value / Orphan Disease Drugs

    Nov 1, 2016, 00:00

  • Evaluation of Social Security Organization'(SSO) Regulations on Physician Prescribing Pattern in Iran in 2014

    Nov 1, 2016, 00:00

  • Prediction Of Costs Associated With The Hospital Management Of Hiv Patients In France Using An Advanced Data Mining Approach On The French Medical Information System Database

    Nov 1, 2016, 00:00

  • Clinical and Comparative Effectiveness of Telemonitoring Intervention Versus Usual Care For Type 2 Diabetes Mellitus- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Early Indicators of Patients with Major Depressive Disorder in Need of Highly Specialized Care- A Systematic Review

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Pharmacological Interventions For Preventing Migraine In Children And Adolescent- A Systematic Review and Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Brentuximab Vedotin in Relapsed or Refractory Hodgkin's Lymphoma Following Autologous Stem Cell Transplant in Taiwan

    Nov 1, 2016, 00:00

  • Do Pharmaceutical Cost Control Policies Effective In Reducing Pharmaceutical Expenditure And Volume? A Systematic Review

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis to Estimate The Economic Consequences Of Introducing The Combination of Avastin + Tarceva for The Treatment of First Line Epidermal Growth Factor (EGFR) Metastatic Non-Small Cell Lung Cancer (NSCLC)

    Nov 1, 2016, 00:00

  • Overview on Epidemiological Data For Multiple Myeloma In Austria

    Nov 1, 2016, 00:00

  • Which Types of Economic Evaluations are Considered by Health Technology Assessment Agencies?

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Panobinostat – Bortezomib and Dexamethasone, As 3rd Or 4th Line of Treatment in Patients with Relapsed/Refractory Multiple Myeloma in Greece

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis For Treatment Of Parkinson’s Disease- A Systematic Review

    Nov 1, 2016, 00:00

  • Effectiveness of Clinical Pharmacist Intervention on Direct Medical Cost in Chronic Obstructive Pulmonary Disorder Patients - A Randomized Controlled Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Oral Fentanyl Formulations for Breakthrough Cancer Pain Treatment

    Nov 1, 2016, 00:00

  • Effectiveness and Safety of Vemurafenib as Monotherapy in Unresectable or Metastatic Melanoma from an Academic Database- Real World Data to Strengthen Evidence for Payer

    Nov 1, 2016, 00:00

  • Using Evidence Reviews To Develop Focused Systematic Review Questions

    Nov 1, 2016, 00:00

  • Assessment of Patient Preferences in the Treatment of Relapsing-Remitting Multiple Sclerosis in Public and Private Systems in Latin America

    Nov 1, 2016, 00:00

  • Resource Utilization and Costs of Resected Pancreatic Cancer Patients Receiving Neoadjuvant Treatment- Findings from a Real-World U.S. Population

    Nov 1, 2016, 00:00

  • Disease Related Knowledge, Medication Adherence And Glycaemic Control Among Patients With Type 2 Diabetes Mellitus In Pakistan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Active Surveillance of Beta-D-Glucan in Intensive Care Units in Hong Kong

    Nov 1, 2016, 00:00

  • Transcatheter Aortic Valve Implantation For Inoperable Severe Aortic Stenosis - A Meta-Analysis

    Nov 1, 2016, 00:00

  • Systemic Adverse Drug Reactions of Antihypertensive Agents

    Nov 1, 2016, 00:00

  • Exploring Interest in The Use of A Complementary Therapy Among Individuals With Copd

    Nov 1, 2016, 00:00

  • Cost-Minimisation Analysis of Sucroferric Oxhydroxide and Sevelamer Carbonate in Patients on Dialysis with Secondary Hyperparathyroidism in Six European Countries

    Nov 1, 2016, 00:00

  • The Hector Study- Health Economics Study of Codeine And Tramadol Non-Responders – A Sub Population Analysis

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis Of Baofukang Versus Langyi In The Treatment Of Vvc

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Analysis of Treatment of Children with Severe Uncontrolled Asthma with Omalizumab In Russia

    Nov 1, 2016, 00:00

  • The American Society of Clinical Oncology (Asco) Net Health Benefit (Nhb) Assessment Tool- Which Implications for Value Assessment of Cancer Therapies?

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir In Treatment Of Chronic Hepatitis C In The Russian Federation

    Nov 1, 2016, 00:00

  • Pharmacotherapy Consultations By Clinical Pharmacists To Improve Quality And Safe Use Of Medicines- An Experience From Tertiary Care Teaching Hospital

    Nov 1, 2016, 00:00

  • Oral Versus Intravenous Iron Treatment in Patients with Inflammatory Bowel Disease and Iron Deficiency and/or Anemia in Germany

    Nov 1, 2016, 00:00

  • Antithrombotic Treatment Pattern in Patients with Atrial Fibrillation in Italy Before and After Xaban/Dtis Launch- The Repair Study Cross-Sectional Results

    Nov 1, 2016, 00:00

  • Cost Effectivess Analysis for Combination of Aspirin and Warfarin Versus Warfarin Alone in Patients with Heart Valve Prosthesis

    Nov 1, 2016, 00:00

  • Beware the Impact of Discount Rates in the Assessment of HPV Vaccines

    Nov 1, 2016, 00:00

  • Missed Opportunities in The Netherlands- The Negligence of Non-Statistical Uncertainty in Ced Policy

    Nov 1, 2016, 00:00

  • The European Social Preference Measurement (ESPM) Study- Conceptual Considerations and Implementation

    Nov 1, 2016, 00:00

  • Healthcare Expenditures and Equity in Healthcare Utilization for Lymphedema Patients in France

    Nov 1, 2016, 00:00

  • A Systematic Review of Tyrosine Kinase Inhibitors as First Line Treatment for Advanced Non Small Cell Lung Cancer

    Nov 1, 2016, 00:00

  • Cost Avoidance Of Pharmacist Running Pediatrics Total Parenteral Nutrition Services At Ministry Of Health In Saudi Arabia

    Nov 1, 2016, 00:00

  • Increasing Efficiency of Pricing and Market Access Decisions By Cross Functional Interactions

    Nov 1, 2016, 00:00

  • Real World Evidence (RWE) to Enhance Value-Based Market Access of the PCSK9 Inihibitors in Italy- Treatment Patterns and Cv-Related Hospitalizations Among High Risk Hefh and Secondary Prevention Patients in Three Real-World Data Systems

    Nov 1, 2016, 00:00

  • Time and Cost of Hospitalization for Salvage Therapy Among Adults with Philadelhphia (PH)-Negative B-Cell Relapsed/Refractory (R/R) Acute Lymphoblastic Leukaemia (ALL) In Spain

    Nov 1, 2016, 00:00

  • Health State Valuation in Sri Lanka Using the EQ-5D-3l; Precursor to Qaly Estimation in South Asia

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Exercise for the Prevention of Cancer

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Threshold Proposal For Bosnia And Herzegovina

    Nov 1, 2016, 00:00

  • Secukinumab In The Management of Psoriatic Arthritis In Gree A Budget Impact Analysis

    Nov 1, 2016, 00:00

  • Determinants of Orphan Drug Prices in Italy and the UK

    Nov 1, 2016, 00:00

  • EQ-5D Studies in Diseases of The Circulatory System in Eight Central and Eastern European Countries

    Nov 1, 2016, 00:00

  • Market Access of Innovative Anticancer Drugs in Algeria- Funding Based on Clinical or Economic Evidence?

    Nov 1, 2016, 00:00

  • Biosimilars And Reference Price Groups In Germany

    Nov 1, 2016, 00:00

  • Accelerated/Malignant Hypertension with a Diagnostic Ambugity- A Retrospective Cohort Study

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Treatment Strategies For Multiple Myeloma in Elderly Patients- A Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Adherence of Patients with Type 2 Diabetes to Medications – The Role Of Risk Preferences

    Nov 1, 2016, 00:00

  • Potential Cost Savings of A Point-Of-Care Diagnostic Test Measuring Antipsychotic Plasma Levels for Treatment of Patients with Schizophrenia in Spain

    Nov 1, 2016, 00:00

  • Multi-Criteria Assessment In HTA Process in the Czech Republic- the Role of Different Stakeholders Involvement and Impact on Appraisal of Drugs Including Orphans

    Nov 1, 2016, 00:00

  • Simulating Patient-Level Profiles To Capture Patient Heterogeneity In Health-Economic Applications

    Nov 1, 2016, 00:00

  • Cost of 1st Line Treatment Failure in Braf V600 Mutated Metastatic Melanoma in France

    Nov 1, 2016, 00:00

  • Budget And Patient Access Analysis To Second Line Therapy Of Multiple Sclerosis In Bulgaria

    Nov 1, 2016, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79 (current)
  • 80
  • »